Busch, M.P.; Eble, B.E.; Khayam-Bashi, H.; Heilbron, D.; Murphy, E.L.; Kwok, S.; Sninsky, J.; Perkins, H.A.; Vyas, G.N.; 외. (1991). “Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells”. 《N. Engl. J. Med.》 325 (1): 1–5. doi:10.1056/NEJM199107043250101. PMID2046708.
Silvester, C.; Healey, D.S.; Cunningham, P.; Dax, E.M. (1995). “Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays. Australian HIV Test Evaluation Group”. 《J Acquir Immune Defic Syndr Hum Retrovirol》 8 (4): 411–19. doi:10.1097/00042560-199504000-00014. PMID7882108.
Urassa, W.; Godoy, K.; Killewo, J.; Kwesigabo, G.; Mbakileki, A.; Mhalu, F.; Biberfeld, G. (1999). “The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania”. 《J. Clin. Virol.》 14 (1): 25–29. doi:10.1016/S1386-6532(99)00043-8. PMID10548127.
Nkengasong, J.N.; Maurice, C.; Koblavi, S.; Kalou, M.; Yavo, D.; Maran, M.; Bile, C.; N'guessan, K.; Kouadio, J.; 외. (1999). “Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Cote d'Ivoire”. 《AIDS》 13 (1): 109–17. doi:10.1097/00002030-199901140-00015. PMID10207552.
Samdal, H.H.; Gutigard, B.G.; Labay, D.; Wiik, S.I.; Skaug, K.; Skar, A.G. (1996). “Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion”. 《Clin. Diagn. Virol》 7 (1): 55–61. doi:10.1016/S0928-0197(96)00244-9. PMID9077430.
Courville, T.M.; Caldwell, B.; Brunell, P.A. (1998). “Lack of evidence of transmission of HIV-1 to family contacts of HIV-1 infected children”. 《Clin. Pediatr.》 37 (3): 175–78. doi:10.1177/000992289803700303. PMID9545605. S2CID30065399.
Locatelli, S; Peeters, M (2012년 3월 27일). “Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population”. 《AIDS》 26 (6): 659–73. doi:10.1097/QAD.0b013e328350fb68. PMID22441170. S2CID38760788.
Ackah, A.N.; Coulibaly, D.; Digbeu, H.; Diallo, K.; Vetter, K.M.; Coulibaly, I.M.; Greenberg, A.E.; De Cock, K.M. (1995). “Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire”. 《Lancet》 345 (8950): 607–10. doi:10.1016/S0140-6736(95)90519-7. PMID7898177. S2CID19384981.
Taha, T.E.; Kumwenda, N.I.; Broadhead, R.L.; Hoover, D.R.; Graham, S.M.; Van Der, Hoven L.; Markakis, D.; Liomba, G.N.; Chiphangwi, J.D.; 외. (1999). “Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children”. 《Pediatr. Infect. Dis. J.》 18 (8): 689–94. doi:10.1097/00006454-199908000-00007. PMID10462337.
Detels, R.; Munoz, A.; McFarlane, G.; Kingsley, L.A.; Margolick, J.B.; Giorgi, J.; Schrager, L.K.; Phair, J.P. (1998). “Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators”. 《JAMA》 280 (17): 1497–503. doi:10.1001/jama.280.17.1497. PMID9809730.
De Martino, M; Tovo, PA; Balducci, M; Galli, L; Gabiano, C; Rezza, G; Pezzotti, P (2000). “Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry”. 《JAMA》 284 (2): 190–97. doi:10.1001/jama.284.2.190. PMID10889592.
Schwarcz, S.K.; Hsu, L.C.; Vittinghoff, E.; Katz, M.H. (2000). “Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987–1996”. 《Am. J. Epidemiol.》 152 (2): 178–85. doi:10.1093/aje/152.2.178. PMID10909955.
Kaplan, JE; Hanson, D; Dworkin, MS; Frederick, T; Bertolli, J; Lindegren, ML; Holmberg, S; Jones, JL (2000). “Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy”. 《Clinical Infectious Diseases》. 30 Suppl 1: S5–S14. doi:10.1086/313843. PMID10770911.
McNaghten, A.D.; Hanson, D.L.; Jones, J.L.; Dworkin, M.S.; Ward, J.W.; The Adultadolescent Spectrum Of Disease Group +/ (1999). “Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group”. 《AIDS》 13 (13): 1687–95. doi:10.1097/00002030-199909100-00012. PMID10509570.
Schechter, M.T.; Craib, K.J.; Gelmon, K.A.; Montaner, J.S.; Le, T.N.; O'Shaughnessy, M.V.; Schechter, M.T.; Gelmon, K.A.; Montaner, J.S.G. (1993). “HIV-1 and the aetiology of AIDS”. 《Lancet》 341 (8846): 658–59. doi:10.1016/0140-6736(93)90421-C. PMID8095571. S2CID23141531.
Vermund, S.H.; Hoover, D.R.; Chen, K. (1993). “CD4+ counts in seronegative homosexual men. The Multicenter AIDS Cohort Study”. 《N. Engl. J. Med.》 328 (6): 442. doi:10.1056/NEJM199302113280615. PMID8093639.
Donegan, E.; Stuart, M.; Niland, J.C.; Sacks, H.S.; Azen, S.P.; Dietrich, S.L.; Faucett, C.; Fletcher, M.A.; Kleinman, S.H.; 외. (1990). “Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations”. 《Annals of Internal Medicine》 113 (10): 733–39. doi:10.7326/0003-4819-113-10-733. PMID2240875.
Gjerset, G.F.; Pike, M.C.; Mosley, J.W.; Hassett, J.; Fletcher, M.A.; Donegan, E.; Parker, J.W.; Counts, R.B.; Zhou, Y.; 외. (1994). “Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group”. 《Blood》 84 (5): 1666–71. doi:10.1182/blood.V84.5.1666.1666. PMID7915149.
Goedert, JJ; Kessler, CM; Aledort, LM; Biggar, RJ; Andes, WA; White Gc, 2nd; Drummond, JE; Vaidya, K; 외. (1989). “A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia”. 《The New England Journal of Medicine》 321 (17): 1141–48. doi:10.1056/NEJM198910263211701. PMID2477702.
Littlewood, RA; Vanable, PA (2011년 12월 8일). “A global perspective on complementary and alternative medicine use among people living with HIV/AIDS in the era of antiretroviral treatment”. 《Curr. HIV/AIDS Rep.》 8 (4): 257–68. doi:10.1007/s11904-011-0090-8. PMID21822625. S2CID20186700.
Busch, M.P.; Eble, B.E.; Khayam-Bashi, H.; Heilbron, D.; Murphy, E.L.; Kwok, S.; Sninsky, J.; Perkins, H.A.; Vyas, G.N.; 외. (1991). “Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells”. 《N. Engl. J. Med.》 325 (1): 1–5. doi:10.1056/NEJM199107043250101. PMID2046708.
Silvester, C.; Healey, D.S.; Cunningham, P.; Dax, E.M. (1995). “Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays. Australian HIV Test Evaluation Group”. 《J Acquir Immune Defic Syndr Hum Retrovirol》 8 (4): 411–19. doi:10.1097/00042560-199504000-00014. PMID7882108.
Urassa, W.; Godoy, K.; Killewo, J.; Kwesigabo, G.; Mbakileki, A.; Mhalu, F.; Biberfeld, G. (1999). “The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania”. 《J. Clin. Virol.》 14 (1): 25–29. doi:10.1016/S1386-6532(99)00043-8. PMID10548127.
Nkengasong, J.N.; Maurice, C.; Koblavi, S.; Kalou, M.; Yavo, D.; Maran, M.; Bile, C.; N'guessan, K.; Kouadio, J.; 외. (1999). “Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Cote d'Ivoire”. 《AIDS》 13 (1): 109–17. doi:10.1097/00002030-199901140-00015. PMID10207552.
Samdal, H.H.; Gutigard, B.G.; Labay, D.; Wiik, S.I.; Skaug, K.; Skar, A.G. (1996). “Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion”. 《Clin. Diagn. Virol》 7 (1): 55–61. doi:10.1016/S0928-0197(96)00244-9. PMID9077430.
Courville, T.M.; Caldwell, B.; Brunell, P.A. (1998). “Lack of evidence of transmission of HIV-1 to family contacts of HIV-1 infected children”. 《Clin. Pediatr.》 37 (3): 175–78. doi:10.1177/000992289803700303. PMID9545605. S2CID30065399.
Resnick, L.; Veren, K.; Salahuddin, S.Z.; Tondreau, S.; Markham, P.D. (1986). “Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments”. 《JAMA》 255 (14): 1887–91. doi:10.1001/jama.255.14.1887. PMID2419594.
Heimer, R.; Abdala, N. (2000). “Viability of HIV-1 in syringes: implications for interventions among injection drug users”. 《AIDS Reader》 10 (7): 410–17. PMID10932845.
Groginsky, E.; Bowdler, N.; Yankowitz, J. (1998). “Update on vertical HIV transmission”. 《J Reprod Med》 43 (8): 637–46. PMID9749412.
Locatelli, S; Peeters, M (2012년 3월 27일). “Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population”. 《AIDS》 26 (6): 659–73. doi:10.1097/QAD.0b013e328350fb68. PMID22441170. S2CID38760788.
Ackah, A.N.; Coulibaly, D.; Digbeu, H.; Diallo, K.; Vetter, K.M.; Coulibaly, I.M.; Greenberg, A.E.; De Cock, K.M. (1995). “Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire”. 《Lancet》 345 (8950): 607–10. doi:10.1016/S0140-6736(95)90519-7. PMID7898177. S2CID19384981.
Taha, T.E.; Kumwenda, N.I.; Broadhead, R.L.; Hoover, D.R.; Graham, S.M.; Van Der, Hoven L.; Markakis, D.; Liomba, G.N.; Chiphangwi, J.D.; 외. (1999). “Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children”. 《Pediatr. Infect. Dis. J.》 18 (8): 689–94. doi:10.1097/00006454-199908000-00007. PMID10462337.
Palella, F.J. Jr; Delaney, K.M.; Moorman, A.C.; Loveless, M.O.; Fuhrer, J.; Satten, G.A.; Aschman, D.J.; Holmberg, S.D. (1998). “Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators”. 《N. Engl. J. Med.》 338 (13): 853–60. doi:10.1056/NEJM199803263381301. PMID9516219.
Mocroft, A.; Vella, S.; Benfield, T.L.; Chiesi, A.; Miller, V.; Gargalianos, P.; Arminio Monforte, A.; Yust, I.; Bruun, J.N.; 외. (1998). “Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group”. 《Lancet》 352 (9142): 1725–30. doi:10.1016/S0140-6736(98)03201-2. PMID9848347. S2CID32223916.
Detels, R.; Munoz, A.; McFarlane, G.; Kingsley, L.A.; Margolick, J.B.; Giorgi, J.; Schrager, L.K.; Phair, J.P. (1998). “Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators”. 《JAMA》 280 (17): 1497–503. doi:10.1001/jama.280.17.1497. PMID9809730.
De Martino, M; Tovo, PA; Balducci, M; Galli, L; Gabiano, C; Rezza, G; Pezzotti, P (2000). “Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry”. 《JAMA》 284 (2): 190–97. doi:10.1001/jama.284.2.190. PMID10889592.
Schwarcz, S.K.; Hsu, L.C.; Vittinghoff, E.; Katz, M.H. (2000). “Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987–1996”. 《Am. J. Epidemiol.》 152 (2): 178–85. doi:10.1093/aje/152.2.178. PMID10909955.
Kaplan, JE; Hanson, D; Dworkin, MS; Frederick, T; Bertolli, J; Lindegren, ML; Holmberg, S; Jones, JL (2000). “Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy”. 《Clinical Infectious Diseases》. 30 Suppl 1: S5–S14. doi:10.1086/313843. PMID10770911.
McNaghten, A.D.; Hanson, D.L.; Jones, J.L.; Dworkin, M.S.; Ward, J.W.; The Adultadolescent Spectrum Of Disease Group +/ (1999). “Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group”. 《AIDS》 13 (13): 1687–95. doi:10.1097/00002030-199909100-00012. PMID10509570.
Schechter, M.T.; Craib, K.J.; Gelmon, K.A.; Montaner, J.S.; Le, T.N.; O'Shaughnessy, M.V.; Schechter, M.T.; Gelmon, K.A.; Montaner, J.S.G. (1993). “HIV-1 and the aetiology of AIDS”. 《Lancet》 341 (8846): 658–59. doi:10.1016/0140-6736(93)90421-C. PMID8095571. S2CID23141531.
Vermund, S.H.; Hoover, D.R.; Chen, K. (1993). “CD4+ counts in seronegative homosexual men. The Multicenter AIDS Cohort Study”. 《N. Engl. J. Med.》 328 (6): 442. doi:10.1056/NEJM199302113280615. PMID8093639.
Gjerset, G.F.; Pike, M.C.; Mosley, J.W.; Hassett, J.; Fletcher, M.A.; Donegan, E.; Parker, J.W.; Counts, R.B.; Zhou, Y.; 외. (1994). “Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group”. 《Blood》 84 (5): 1666–71. doi:10.1182/blood.V84.5.1666.1666. PMID7915149.
Goedert, JJ; Kessler, CM; Aledort, LM; Biggar, RJ; Andes, WA; White Gc, 2nd; Drummond, JE; Vaidya, K; 외. (1989). “A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia”. 《The New England Journal of Medicine》 321 (17): 1141–48. doi:10.1056/NEJM198910263211701. PMID2477702.
Littlewood, RA; Vanable, PA (2011년 12월 8일). “A global perspective on complementary and alternative medicine use among people living with HIV/AIDS in the era of antiretroviral treatment”. 《Curr. HIV/AIDS Rep.》 8 (4): 257–68. doi:10.1007/s11904-011-0090-8. PMID21822625. S2CID20186700.
Altman, Lawrence K. (July 11, 1997). “The New York Times”. 《Case of H.I.V. Transmission Is First to Be Linked to Kiss》. July 1st, 2021에 확인함.다음 날짜 값 확인 필요: |access-date= (도움말)
Courville, T.M.; Caldwell, B.; Brunell, P.A. (1998). “Lack of evidence of transmission of HIV-1 to family contacts of HIV-1 infected children”. 《Clin. Pediatr.》 37 (3): 175–78. doi:10.1177/000992289803700303. PMID9545605. S2CID30065399.
Locatelli, S; Peeters, M (2012년 3월 27일). “Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population”. 《AIDS》 26 (6): 659–73. doi:10.1097/QAD.0b013e328350fb68. PMID22441170. S2CID38760788.
Zhu, T.; Korber, B.T.; Nahmias, A.J.; Hooper, E.; Sharp, P.M.; Ho, D.D. (1998). “An African HIV-1 sequence from 1959 and implications for the origin of the epidemic”. 《Nature》 391 (6667): 594–97. Bibcode:1998Natur.391..594Z. doi:10.1038/35400. PMID9468138. S2CID4416837.
Ackah, A.N.; Coulibaly, D.; Digbeu, H.; Diallo, K.; Vetter, K.M.; Coulibaly, I.M.; Greenberg, A.E.; De Cock, K.M. (1995). “Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire”. 《Lancet》 345 (8950): 607–10. doi:10.1016/S0140-6736(95)90519-7. PMID7898177. S2CID19384981.
Mocroft, A.; Vella, S.; Benfield, T.L.; Chiesi, A.; Miller, V.; Gargalianos, P.; Arminio Monforte, A.; Yust, I.; Bruun, J.N.; 외. (1998). “Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group”. 《Lancet》 352 (9142): 1725–30. doi:10.1016/S0140-6736(98)03201-2. PMID9848347. S2CID32223916.
Littlewood, RA; Vanable, PA (2011년 12월 8일). “A global perspective on complementary and alternative medicine use among people living with HIV/AIDS in the era of antiretroviral treatment”. 《Curr. HIV/AIDS Rep.》 8 (4): 257–68. doi:10.1007/s11904-011-0090-8. PMID21822625. S2CID20186700.